News Focus
News Focus
icon url

cheynew

04/05/16 5:14 PM

#260892 RE: Protector #260888

With all due respect, I think you are grasping at straws. I believe Bavi + chemo is, as King said, shelved and the focus going forward is I/O. It joins Cotara on the shelf IMO. Maybe you have some basis for thinking they could take it to the FDA, but the reality is no one has ever gotten approval based on a terminated trial, if I am reading some of the knowledgeable posters correctly.
icon url

north40000

04/05/16 6:11 PM

#260908 RE: Protector #260888

"So if IBM can explain..." I did not know IBM was involved with PPHM at all
icon url

revenue_monster

04/05/16 6:19 PM

#260909 RE: Protector #260888

The did tell us they stopped the trial. What are you waiting for? I would say stopped and discontinued are one in the same.
TUSTIN, Calif., Feb. 25, 2016 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a biopharmaceutical company focused on developing therapeutics to stimulate the body's immune system to fight cancer, today announced that it is discontinuing the company's Phase III SUNRISE trial of bavituximab in patients with previously treated locally advanced or metastatic n
icon url

Carboat

04/05/16 11:09 PM

#260941 RE: Protector #260888

I do not believe it is death, although I wish it was because I like the 100% I-O path better

So you wish they never got PIII approval?